Comparison of Lotrafilcon B Lenses With Different Packaging Solutions
Status: | Recruiting |
---|---|
Conditions: | Ocular |
Therapuetic Areas: | Ophthalmology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 8/18/2016 |
Start Date: | May 2016 |
End Date: | October 2016 |
Contact: | Alcon Call Center |
Email: | alcon.medinfo@alcon.com |
Phone: | 1-800-451-3937 |
One Month Clinical Comparison of Two Lotrafilcon B Spherical Lenses With Different Packaging Solutions
The purpose of this study is to evaluate AIR OPTIX® plus HYDRAGLYDE® (AOHG) contact lenses
compared to AIR OPTIX® AQUA (AOA) contact lenses in overall lens fit.
compared to AIR OPTIX® AQUA (AOA) contact lenses in overall lens fit.
Subjects must not wear any contact lenses prior to the visit on Day 1 (Insertion) for Period
1 or Day 1 (Insertion) for Period 2. This study will be conducted in the United Kingdom.
1 or Day 1 (Insertion) for Period 2. This study will be conducted in the United Kingdom.
Inclusion Criteria:
- Must sign Informed Consent Document;
- Manifest cylinder less than or equal to 0.75 Diopter (D) in each eye;
- Successful current wearer (during the past 2 months for a minimum of 5 days per week
and 8 hours per day) of AOA contact lenses within the protocol-specified power range;
- Willing to answer text messages on a daily basis during the study;
- Willing to discontinue artificial tears and rewetting drops on the days of study
visits;
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
- Habitual lens wear in an extended wear modality (routinely sleeping in lenses
overnight for 1 night per week);
- Any anterior segment infection, inflammation, disease or abnormality that
contraindicates contact lens wear (within 7 days of enrollment, or current);
- History of herpetic keratitis, corneal surgery or irregular cornea;
- Any use of systemic or ocular medications for which contact lens wear could be
contraindicated;
- Monocular (only 1 eye with functional vision) or fit with only 1 lens;
- Pregnant or lactating;
- Participation in any clinical study within 30 days of Visit 1;
- Other protocol-specified exclusion criteria may apply.
We found this trial at
1
site
Click here to add this to my saved trials